Novo Nordisk reported weaker-than-expected second-quarter net profit on Wednesday and revised down its operating profit forecast. The pharmaceutical giant said ...
Whether you're ready or not, back-to-school season is here, and children are bringing home greater than just homework. They're also ...
The U.S. Food and Drug Administration has rejected approval of the psychedelic drug MDMA for the treatment of PTSD, ending ...
Investors need to know if Eli Lilly will face the identical pricing pressure on its blockbuster weight-loss drug Zepbound that ...
Huntington Health staff and patients followed the Olympic news and were overjoyed to acknowledge a well-known, fluffy face. Beacon, a ...
Eli Lilly reported on Thursday Second quarter results and revenue exceeded all expectations, raising full-year revenue guidance by $3 billion ...
Over the years, growing evidence has revealed a stark injustice: in comparison with wealthy cities, poorer cities are disproportionately affected ...
CVS Health on Wednesday slashed The company again revised upward its full-year earnings outlook and announced a brand new $2 ...
TOKYO – More than 120 people died of warmth stroke within the greater Tokyo area in July because the country's ...
Anne Wojcicki, CEO of 23andMehas filed to take the genetic testing company private as its share price stays below $1. ...